V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

Abstract Background Anemia is common among end-stage renal disease (ESRD) patients who undergone hemodialysis. The total reduction of red blood cell (RBC) count is associated with poor prognosis in these patients. Although erythropoietin (EPO) has been used as an effective treatment for ESRD patient...

Full description

Bibliographic Details
Main Authors: Henry Sung-Ching Wong, Che-Mai Chang, Chih-Chin Kao, Yu-Wen Hsu, Xiao Liu, Wen-Chang Chang, Mai-Szu Wu, Wei-Chiao Chang
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Journal of Biomedical Science
Subjects:
End-stage renal disease
Erythropoietin treatment
T-cell receptor repertoire
High-throughput sequencing
Online Access:http://link.springer.com/article/10.1186/s12929-017-0349-5

Internet

http://link.springer.com/article/10.1186/s12929-017-0349-5

Similar Items